Biotech Values

[DewDiligence]

>IDIX – however, that IMHO, does not exclude the opportunity for a financing assuming two things…<

Agree that IDIX may want to raise capital in 2009, but probably not at $5/sh. At $10/sh, they likely would, IMO.

>…they license a portion more of the company to BP for more operating capital, when the timing is right.<

Bear in mind that NVS owns a 56% equity stake; it’s therefore unlikely that a third party would take an equity stake.

On the other hand, a partnership deal for IDX899 figures to bring in some serious up-front cash from a company other than NVS.

The CC link: http://biz.yahoo.com/cc/2/98182.html